NBY Competitors & Alternatives
Compare NovaBay Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
NBY
Main Stock$1.95
Tradestie Score
43
Market Cap
$8.23M
Revenue Growth
-0.8%
Analyst Upside
-56.4%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$35.38
|
$110.20M | - | 40 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.67
|
$97.42M | - | 45 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.95
|
$84.52M | - | 50 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.30
|
$71.32M | - | 41 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$14.03
|
$67.94M | - | 35 | Compare |
|
SINT
SiNtx Technologies, Inc. Common Stock
|
$1.53
|
$11.23M | - | 48 | Compare |
|
SNGX
Soligenix, Inc. Common Stock
|
$0.38
|
$10.38M | - | 47 | Compare |
|
OGEN
Oragenics Inc.
|
$0.51
|
$5.86M | 0.5 | 40 | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
|
GHSI
GHSI
|
- | - | - | - | Compare |
More NBY Analysis
Data updated: Aug 31, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry